Literature DB >> 24927134

Evaluation of cytotoxicity and DNA damage response with analysis of intracellular ATM signaling pathways.

Sriram Bandi1, Preeti Viswanathan, Sanjeev Gupta.   

Abstract

Maintenance of genome integrity by preventing and overcoming DNA damage is critical for cell survival. Deficiency or aberrancy in the DNA damage response, for example, through ataxia telangiectasia mutated (ATM) signaling, lead to pathophysiological perturbations in organs throughout the body. Therefore, control of DNA damage is of major interest for development of therapeutic agents. Such efforts will greatly benefit from convenient and simple diagnostic and/or drug development tools to demonstrate whether ATM and related genes have been activated and to then determine whether these have been returned to normal levels of activity because pathway members sense and also repair DNA damage. To overcome difficulties in analyzing differences in multitudinous ATM pathway members following DNA damage, we measured ATM promoter activity with a fluorescent td-Tomato reporter gene to interrogate the global effects of ATM signaling pathways. In cultured HuH-7 cell line derived from human hepatocellular carcinoma, cis-platinum, acetaminophen, or hydrogen peroxide caused DNA strand breaks and ATM pathway activation as shown by γH2AX expression, which in turn, led to rapid and sustained increases in ATM promoter activity. This assay of ATM promoter activity identified biological agents capable of controlling cellular DNA damage in toxin-treated HuH-7 cells and in mice after onset of drug-induced acute liver failure. Therefore, the proposed assay of ATM promoter activity in HuH-7 cells was appropriately informative for treating DNA damage. High-throughput screens using ATM promoter activation will be helpful for therapeutic development in DNA damage-associated abnormal ATM signaling in various cell types and organs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24927134      PMCID: PMC4060777          DOI: 10.1089/adt.2014.571

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  34 in total

1.  Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors.

Authors:  A Follenzi; G Sabatino; A Lombardo; C Boccaccio; L Naldini
Journal:  Hum Gene Ther       Date:  2002-01-20       Impact factor: 5.695

2.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein.

Authors:  Nathan C Shaner; Robert E Campbell; Paul A Steinbach; Ben N G Giepmans; Amy E Palmer; Roger Y Tsien
Journal:  Nat Biotechnol       Date:  2004-11-21       Impact factor: 54.908

3.  MKK7 and ARF: new players in the DNA damage response scenery.

Authors:  Athanassios Kotsinas; Panagiota Papanagnou; Panagiotis Galanos; Daniel Schramek; Paul Townsend; Josef M Penninger; Jiri Bartek; Vassilis G Gorgoulis
Journal:  Cell Cycle       Date:  2014-03-26       Impact factor: 4.534

4.  Regulation of the Atm promoter in vivo.

Authors:  Nuri Gueven; Toshiyuki Fukao; John Luff; Carol Paterson; Graham Kay; Naomi Kondo; Martin F Lavin
Journal:  Genes Chromosomes Cancer       Date:  2006-01       Impact factor: 5.006

5.  Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA.

Authors:  A R Collins; S J Duthie; V L Dobson
Journal:  Carcinogenesis       Date:  1993-09       Impact factor: 4.944

6.  A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.

Authors:  Jung-Jung Mu; Yi Wang; Hao Luo; Mei Leng; Jinglan Zhang; Tao Yang; Dario Besusso; Sung Yun Jung; Jun Qin
Journal:  J Biol Chem       Date:  2007-05-03       Impact factor: 5.157

Review 7.  MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

Authors:  Bernd Kaina; Markus Christmann; Steffen Naumann; Wynand P Roos
Journal:  DNA Repair (Amst)       Date:  2007-05-07

8.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

Review 9.  An oncogene-induced DNA damage model for cancer development.

Authors:  Thanos D Halazonetis; Vassilis G Gorgoulis; Jiri Bartek
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

10.  Exploring protein phosphorylation in response to DNA damage using differentially tagged yeast arrays.

Authors:  Bernhard Suter; Christopher Graham; Igor Stagljar
Journal:  Biotechniques       Date:  2008-11       Impact factor: 1.993

View more
  10 in total

1.  Efficient Reconstitution of Hepatic Microvasculature by Endothelin Receptor Antagonism in Liver Sinusoidal Endothelial Cells.

Authors:  Neelam Yadav; Fadi Luc Jaber; Yogeshwar Sharma; Priya Gupta; Preeti Viswanathan; Sanjeev Gupta
Journal:  Hum Gene Ther       Date:  2018-12-18       Impact factor: 5.695

2.  Replicative stress and alterations in cell cycle checkpoint controls following acetaminophen hepatotoxicity restrict liver regeneration.

Authors:  Preeti Viswanathan; Yogeshwar Sharma; Priya Gupta; Sanjeev Gupta
Journal:  Cell Prolif       Date:  2018-03-05       Impact factor: 6.831

3.  Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.

Authors:  Samriti Dogra; Sriram Bandi; Preeti Viswanathan; Sanjeev Gupta
Journal:  Cancer Lett       Date:  2014-11-10       Impact factor: 8.679

4.  Ataxia telangiectasia mutated pathway disruption affects hepatic DNA and tissue damage in nonalcoholic fatty liver disease.

Authors:  Preeti Viswanathan; Yogeshwar Sharma; Luka Maisuradze; Tatyana Tchaikovskaya; Sanjeev Gupta
Journal:  Exp Mol Pathol       Date:  2020-01-07       Impact factor: 3.362

5.  Abnormal Expression of DNA Double-Strand Breaks Related Genes, ATM and GammaH2AX, in Thyroid Carcinoma.

Authors:  Jin-Lin Hu; Si-Si Hu; Xiu-Xiu Hou; Xin Zhu; Jun Cao; Lie-Hao Jiang; Ming-Hua Ge
Journal:  Int J Endocrinol       Date:  2015-03-16       Impact factor: 3.257

6.  RNF168 is highly expressed in esophageal squamous cell carcinoma and contributes to the malignant behaviors in association with the Wnt/β-catenin signaling pathway.

Authors:  Yunjiu Gou; Dacheng Jin; Shengliang He; Songchen Han; Qizhou Bai
Journal:  Aging (Albany NY)       Date:  2021-01-25       Impact factor: 5.682

7.  Unraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury.

Authors:  M M Heldring; A H Shaw; J B Beltman
Journal:  NPJ Syst Biol Appl       Date:  2022-08-06

8.  MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury.

Authors:  Chaiyaboot Ariyachet; Nattaya Chuaypen; Pornchai Kaewsapsak; Naphat Chantaravisoot; Depicha Jindatip; Saranyapin Potikanond; Pisit Tangkijvanich
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

9.  A novel topoisomerase I inhibitor DIA-001 induces DNA damage mediated cell cycle arrest and apoptosis in cancer cell.

Authors:  Jiaqi Liu; Guohe Geng; Guang Liang; Ling Wang; Kuntian Luo; Jian Yuan; Shiguang Zhao
Journal:  Ann Transl Med       Date:  2020-02

10.  HDAC6 inhibitor ACY1215 inhibits the activation of NLRP3 inflammasome in acute liver failure by regulating the ATM/F-actin signalling pathway.

Authors:  Qian Chen; Yao Wang; Fangzhou Jiao; Pan Cao; Chunxia Shi; Maohua Pei; Luwen Wang; Zuojiong Gong
Journal:  J Cell Mol Med       Date:  2021-06-27       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.